Impact of Prior Therapies and Risk Factors on AML Transformed from MDS
The following is a summary of “Outcomes of Patients With Treated Secondary Acute Myeloid Leukemia: A High-Risk Subtype That Warrants an Independent Prognostic Designation,” published in the December 2024 issue of Hem ...
